Arterial stiffness and wave reflections in patients with sickle cell disease

Hypertension

Volumn 44, Issue 6, 2004, Pages 924-929

  Lemogoum, Daniel ^a   Van Bortel, Luc ^b   Najem, Boutaina ^a   Dzudie, Anasthase ^c   Teutcha, Charles ^c   Madu, Ernest ^d   Leeman, Marc ^a   Degaute, Jean Paul ^a   Van De Borne, Philippe ^a  

^a ERASME HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c YAOUNDÉ CENTRAL HOSPITAL   (Cameroon)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

Arteries; Wave reflections

Indexed keywords

HEMOGLOBIN VARIANT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTERY; ARTICLE; BLOOD PRESSURE; BODY HEIGHT; BODY MASS; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; FEMALE; FEMORAL ARTERY; GENDER; GENOTYPE; HEART RATE; HUMAN; MALE; MEAN ARTERIAL PRESSURE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PULSE WAVE; RADIAL ARTERY; RECORDING; RIGIDITY; SICKLE CELL ANEMIA; STATISTICAL SIGNIFICANCE; VASODILATATION;

ADULT; ANEMIA, SICKLE CELL; ARTERIES; BLOOD FLOW VELOCITY; BLOOD PRESSURE; FEMALE; HEART RATE; HEMOGLOBIN A; HEMOGLOBIN, SICKLE; HUMANS; MALE; REGRESSION ANALYSIS; VASODILATION;

EID: 9644262317     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000148506.73622.ba     Document Type: Article

References (34)

1. Pegelow CH, Colangelo L, Steinberg M, Wright EC, Smith J, Phillips G. Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia. Am J Med. 1997;102:171-177.
2. Ernst AA, Weiss SJ, Johnson WD, Takakuwa KM. Blood pressure in acute vaso-occlusive crises of sickle cell disease. South Med J. 2000;93:590-592.
3. Hatch FE, Crowe LR, Miles DE, Young JP, Portner ME. Altered vascular reactivity in sickle hemoglobinopathy. A possible protective factor from hypertension. Am J Hypertens. 1989;2:2-8.
4. Stuart MJ, Setty BN. Sickle cell acute chest syndrome: pathogenesis and rationale for treatment. Blood. 1999;94:1555-1560.
5. Weiner DL, Hibberd PL, Betit P, Cooper AB, Botelho CA, Brugnara C. Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. JAMA. 2003;289:1136-1142.
6. Morris CR, Kuypers FA, Larkin S, Vichinsky EP, Styles LA. Patterns of arginine and nitric oxide in patients with sickle cell disease with vasoocclusive crisis and acute chest syndrome. J Pediatr Hematol Oncol. 2000;22:515-520.
7. rd. Divergent nitric oxide bioavailability in men and women with sickle cell disease. Circulation. 2003;107:271-278.
8. Rees DC, Cervi P, Grimwade D, O'Driscoll A, Hamilton M, Parker NE, Porter JB. The metabolites of nitric oxide in sickle-cell disease. Br J Haematol. 1995;91:834-837.
9. Belhassen L, Pelle G, Sediame S, Bachir D, Carville C, Bucherer C, Lacombe C, Galacteros F, Adnot S. Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation. Blood. 2001;97:1584-1589.
10. Ruschitzka FT, Wenger RH, Stallmach T, Quascning T, de Wit C, Wagner K, Labugger R, Kelm M, Noll G, Rulicke T, Shaw S, Lindberg RL, Rodenwaldt B, Lutz H, Bauer C, Luscher TF, Gassmann M. Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proc Natl Acad Sci U S A. 2000;97:11609-11613.
11. Nath KA, Shah V, Haggard JJ, Croatt AJ, Smith LA, Hebbel RP, Katusic ZS. Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease. Am J Physiol Regul Integr Comp Physiol. 2000;279:R1949-R1955.
12. Morris CR, Morris SMJ, Hagar W, Van Warmerdam J, Claster S, Kepka-Lenhart D, Machado L, Kuypers FA, Vichinsky EP. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease? Am J Respir Crit Care Med. 2003;168:63-69.
13. Manci EA, Culberson DE, Yang YM, Gardner TM, Powell R, Haynes J Jr., Shah AK, Mankad VN, Investigators of the Cooperative Study of Sickle Cell Disease. Causes of death in sickle cell disease: an autopsy study. Br J Haematol. 2003;123:359-365.
14. Acar P, Maunoury C, de Montalembert M, Dulac Y. Abnormalities of myocardial perfusion in sickle cell disease in childhood: a study of myocardial scintigraphy. Arch Mal Coeur Vaiss. 2003;96:507-510.
15. O'Rourke M. Mechanical principles in arterial disease. Hypertension. 1995;26:2-9.
16. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. I. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236-1241.
17. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension. 1999;33:1111-1117.
18. Nichols WW, O'Rourke MF. McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles, 4th ed. London, UK: Edwin Arnold 1998:54-401.
19. Kelly R, Hayward C, Avolio A, O'Rourke MF. Noninvasive determination of age-related changes in the human arterial pulse. Circulation. 1989;80:1652-1659.
20. Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, Target R, Levi BI. Assessment of arterial distensibility by automatic pulse wave velocity measurement: validation and clinical application studies. Hypertension. 1995;26:485-490.
21. Bramwell JC, Hill AV, McSwiney. The velocity of the pulse wave in man in relation to age as measured by the hot-wire sphygmograph. Heart. 1923;10:233-255.
22. Chen CH, Nevo E, Fetics B, PaK PH, Yin FC, Maughan WL, Kass DA. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation. 1997;95:1827-1836.
23. Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, Crockcroft JR, Webb DJ. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens. 1998;16:2079-2084.
24. Savage MT, Ferro CJ, Pinder SJ, Tomson CR. Reproducibility of derived central arterial waveforms in patients with chronic renal failure. Clin Sci (Lond). 2002;103:59-65.
25. Nigam A, Mitchell GF, Lambert J, Tardif JC. Relation between conduit vessel stiffness (assessed by tonometry) and endothelial function (assessed by flow-mediated dilatation) in patients with and without coronary heart disease. Am J Cardiol. 2003;92:395-399.
26. Smulyan H, Marchais SJ, Pannier B, Guerin AP, Safar ME, London GM. Influence of body height on pulsatile arterial hemodynamic data. J Am Coll Cardiol. 1998;31:1103-1109.
27. Wilkinson IB, Prasad K, Hall IR, Thomas A, MacCallum H, Webb DJ, Frenneaux MP, Crockcroft JR. Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia. J Am Coll Cardiol. 2002;39:1005-1011.
28. Wilkinson IB, Mohammad NH, Tyrrell S, Hall IR, Webb DJ, Paul VE, Levy T, Crockcroft JR. Heart rate dependency of pulse pressure amplification and arterial stiffness. Am J Hypertens. 2002;15:24-30.
29. Ferreira AV, Viana MC, Mill JG, Asmar RG, Cunha RS. Racial differences in aortic stiffness in normotensive and hypertensive adults. J Hypertens. 1999;17:631-637.
30. Cheung YK, Chan GCF, Ha SY. Arterial Stiffness and Endothelial Function in Patients With β-thalassemia major. Circulation. 2002;106:2561-2566.
31. Eberhardt RT, MCMahon I, Duffy ST, Steinberg MH, Perrine SP, Loscalzo J, Coffman JD, Vita JA. Sickle cell anemia is associated with reduced nitric oxide bioactivity in peripheral conduit and resistance vessels. Am J Hematol. 2003;74:104-111.
32. Aslan M, Ryan TM, Adler B, Townes TM, Parks DA, Thompson JA, Tousson A, Gladwin MT, Patel RP, Tarpey MM, Batinic-Haberle I, White CR, Freedman BA. Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc Nat Acad Sci USA. 2001;98:15215-15220.
33. Kaul DK, Liu XD, Fabry ME, Nagel RL. Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse. Am J Physiol Heart Circ Physiol. 2000;278:H1799-H1806.
34. Reiter CD, Wang X, Tanus-Santos JE, Hogg N, Cannon RO 3rd, Schechter AN, Gladwin MT. Cell-free hemoglobin limits nitric oxide bioavailability in sickle cell disease. Nat Med. 2002;8:1383-1389.